Correction to Novo Nordisk Drug Article
24 December 2014 - 10:22AM
Dow Jones News
The Novo Nordisk AS diabetes drug approved by the FDA is
Liraglutide. "FDA Approves Novo Nordisk Diabetes Drug's Use to
Fight Obesity," at 4:15 p.m. EST, misstated the name of the drug in
the second paragraph.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Apr 2024 to May 2024
Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From May 2023 to May 2024